Donna R. Rill
Chief Development Officer
Life Sciences
Acer Therapeutics
United States of America
Biography
Donna Rill has nearly 30 years of extensive clinical and research laboratory experience in cell and gene therapy research and clinical application, immunological techniques and assessment, microbiology, diagnostic virology, experimental design and method development and implementation. She brings her expertise in the areas of laboratory development and operations, FDA cGMP (current Good Manufacturing Practices) and regulatory compliance, quality control/assurance system development and clinical Standards of Practice. She has worked to design, and qualify cGMP Cell & Gene Therapy Laboratories, cGMP Vector Production facilities, and Translational Research Labs at St. Jude Children’s Research Hospital, Texas Children¹s Hospital and Baylor College of Medicine.
Research Interest
Donna Rill clinical and research laboratory experience in cell and gene therapy research and clinical application, immunological techniques and assessment, microbiology, diagnostic virology, experimental design and method development and implementation.